WW International (WW) said Monday it is incorporating the newly US Food and Drug Administration-approved daily Wegovy pill by Novo Nordisk (NVO) into its weight health GLP-1 platform.
The addition of the oral medication provides an alternative to injectable treatments for members seeking clinically supported options.
Participants in the Weight Watchers Med+ program can obtain the oral medication starting at $149 per month.
The integrated service model pairs the medication with behavioral coaching and digital tools intended to manage side effects and improve results, according to the company.
Shares of WW International were up more than 5% in recent trading.
Price: 33.10, Change: +1.66, Percent Change: +5.28